Verastem | VSTM - Cash And Equivalent

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $117.57M in Cash and Equivalent for its fiscal quarter ending in March of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.63B 838M Sep/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Curis USD 10.14M 10.14M Jun/2025
Cytokinetics USD 225.47M 150.53M Sep/2025
Gilead Sciences USD 7.33B 2.19B Sep/2025
Incyte USD 3.58B 650.78M Dec/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
TG Therapeutics USD 178.32M 100.54M Sep/2025
Verastem USD 117.57M 28.75M Mar/2025